Dow Down 0.02% Nasdaq Up 0.07%

Esperion Therapeutics, Inc. (ESPR)

-NasdaqGM
30.75 Down 0.24(0.77%) 4:00PM EST
Prev Close:30.99
Open:31.32
Bid:28.50 x 200
Ask:30.99 x 400
1y Target Est:46.67
Beta:2.340
Next Earnings Date:N/A
Day's Range:30.59 - 31.34
52wk Range:10.90 - 34.42
Volume:214,920
Avg Vol (3m):306,098
Market Cap:474.87M
P/E (ttm):N/A
EPS (ttm):-2.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ESPR

Comparison

Symbol% ChgMkt Cap
ESPRDown 0.77%474.87M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.29
Quarterly EPS Est (Dec-14) :-0.55
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):4.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Esperion Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of oral, low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholestero... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback